US75886F1075 - REGN - 881535 (XNAS)
REGENERON PHARMACEUTICALS INC Aktie
706,33 USD
Aktuelle Kurse von REGENERON PHARMACEUTICALS INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
REGN
|
USD
|
20.12.2024 23:12
|
706,33 USD
| 708,25 USD | -0,27 % |
London |
0R2M.L
|
USD
|
20.12.2024 17:04
|
711,43 USD
| 708,25 USD | 0,45 % |
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -3,41 % | -5,13 % | -38,31 % | -32,93 % | -16,70 % | 88,04 % |
Firmenprofil zu REGENERON PHARMACEUTICALS INC Aktie
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
Investierte Fonds
Folgende Fonds haben in investiert: REGENERON PHARMACEUTICALS INC investiert:
Fonds | Vol. in Mio 2.094,68 | Anteil (%) 4,91 % |
Fonds | Vol. in Mio 23.196,45 | Anteil (%) 1,33 % |
Fonds | Vol. in Mio 1.295,63 | Anteil (%) 1,25 % |
Fonds | Vol. in Mio 33,86 | Anteil (%) 1,25 % |
Fonds | Vol. in Mio 3.294,59 | Anteil (%) 0,90 % |
Unternehmensdaten zur REGENERON PHARMACEUTICALS INC Aktie
Name REGENERON PHARMACEUTICALS INC
Firma Regeneron Pharmaceuticals, Inc.
Symbol REGN
Website https://www.regeneron.com
Heimatbörse
NASDAQ
WKN 881535
ISIN US75886F1075
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Leonard S. Schleifer M.D., Ph.D.
Marktkapitalisierung 123 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 13,9 T
Adresse 777 Old Saw Mill River Road, 10591-6707 Tarrytown
IPO Datum 1991-04-02
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | RGO.F |
London | 0R2M.L |
NASDAQ | REGN |
Weitere Aktien
Investoren die REGENERON PHARMACEUTICALS INC die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.